The Texas stem cell clinic, Celltex, is lately becoming a model of transparency in the biotech industry. They are willing to answer many (if not all) questions I’ve been asking them. Celltex is involved in stem cell isolation and multiplication, and banking (see post here on the pros and cons of stem cell banking) as […]
Interesting new insights into Celltex’s business model Read More »
I keep seeing these eerie parallels between thalidomide & dubious stem cell treatments. What’s the first rule of medicine again? Do no harm! Rushing new medicines such as stem cell treatments to patients without appropriate preliminary studies to try to make money is like playing Russian Roulette with patients. Some of the time, everything will
Eerie parallels between thalidomide & dubious stem cell treatments Read More »
Celltex is an adult stem cell company in the great state of Texas that reportedly has produced adult stem cell products used for the treatment of more than 100 patients with stem cells. We don’t know much about Celltex (e.g. it has no website), but I was hoping to change that in part via a
Predictions heat up on FDA audit of Celltex Read More »
Last year one of the biggest events in the stem cell field was biotech Geron punting its embryonic stem cell (ESC) program. Much consternation followed. Some folks opposed to ESCs happily pronounced ESC research dead. Some folks in favor of ESC thought the world was ending a year early. Others tried to look on the
The stem cell gestalt of Geron Goodbye and the future of ACT Read More »
TGIF It’s been a wild week on this blog with many thoughts going out to the future of stem cells in Texas. What about stem cell headlines of the week? Some wildness there too and lots of discussion of translational applications, which is exciting. This week let’s start in reverse order with the ugly and
TGIF: good, bad, ugly stem cell headlines of week of May 25 Read More »
I have interviewed two folks on the very important US vs. Regenerative Sciences legal case: Dr. Chris Centeno and Doug Sipp. More background on the case can be found at the FDA Law Blog. I thank them both for their time and for sharing their unique perspectives. I have specific rules for these interviews and
Centeno and Sipp interview on FDA stem cell oversight Read More »
Where do we stand on stem cells for eye disorders? The only biotech with an active hESC-based clinical trial, Advanced Cell Technology (ACT) will have three top leaders including CEO Gary Rabin participating in a CIRM webinar on stem cell-based treatments for eye disorders this Wednesday. Also involved with be Samuel Barone, a medical officer
Stem cells for eye disorders webinar: CIRM, ACT, and FDA together Read More »
The heat is rising in a push to deregulate dubious adult stem cell therapies and it is Republicans turning up the thermostat on this emerging pet issue of theirs. We’ve seen the Texas Medical Board passing weak rules for regulating adult stem cell therapies under pressure from Rick Perry and adult stem cell biotech, Celltex.
Stem cell deregulation push is deadly serious threat to the field and patients Read More »
The Vatican has reportedly killed its planned upcoming stem cell conference. What’s the scoop? Last year the Vatican had an invitation only stem cell conference at which embryonic stem cell researchers, who are presumably going to Hell, and discussion of embryonic stem cell research were banned. I did a number of posts on this 2011
Vatican in turmoil as it kills its upcoming stem cell conference Read More »
What’s the deal with the Pepsi stem cell myth? Does Pepsi have stem cells or ingredients from stem cells in it? No. Does the Pepsi corporation use embryonic stem cells to make Pepsi? No. These are myths. Nonetheless, pro-life extremists have been targeting Pepsi because of these fake connections between Pepsi and stem cells as
SEC rules in favor of Pepsi on bogus stem cell propaganda complaint over 293 cells Read More »